⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10902977 | 0.78 | — | — | |
| SCHEMBL749800 | 0.75 | — | — | |
| SCHEMBL6017143 | 0.75 | — | — | |
| SCHEMBL4639726 | 0.75 | — | — | |
| SCHEMBL5805663 | 0.72 | — | — | |
| SCHEMBL3975421 | 0.72 | LMNA (0.32) | — | |
| SCHEMBL7373886 | 0.70 | NR5A1 (0.35) | — | |
| SCHEMBL8441081 | 0.70 | — | — | |
| SCHEMBL2084086 | 0.70 | — | — | |
| SCHEMBL1804487 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2056829-A2 | USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER | Exelixis, Inc. (US) | 2009-05-13 | — | — | EP | claimed |
| EP-1888063-B1 | ANTIFUNGAL AGENTS | F2G LTD (GB) | 2009-01-14 | — | — | EP | claimed |
| WO-2008021389-A2 | USING PI3K AND MEK MODULATORS IN TREATMENTS OF CANCER | EXELIXIS, INC. (US) | 2008-02-21 | — | — | WO | claimed |
| EP-1542999-A1 | 1H-PYRAZOLE AND 1H-PYRROLE-AZABICYCLIC COMPOUNDS WITH ALFA-7 NACHR ACTIVITY | Pharmacia & Upjohn Company LLC (US) | 2005-06-22 | — | — | EP | claimed |
| WO-2004013137-A1 | 1H-PYRAZOLE AND 1H-PYRROLE-AZABICYCLIC COMPOUNDS WITH ALFA-7 NACHR ACTIVITY | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-02-12 | — | — | WO | claimed |
| EP-0003359-B1 | SPECIFIC OPTICAL ISOMERS OF 2-AMINOETHYL-1,4-BENZODIOXANES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS | CIBA-GEIGY AG (CH) | 1981-02-11 | — | — | EP | claimed |
| US-10077288-B2 | Hydroxystatin derivatives for the treatment of arthrosis | MERCK PATENT GMBH (DE) | 2018-09-18 | — | — | US | disclosed |
| US-9624264-B2 | Hydroxystatin derivatives for the treatment of arthrosis | MERCK PATENT GMBH (DE) | 2017-04-18 | — | — | US | disclosed |
| US-20170081361-A1 | HYDROXYSTATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| EP-3019480-A1 | 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER | Agios Pharmaceuticals, Inc. (US) | 2016-05-18 | — | — | EP | disclosed |
| US-9145373-B2 | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof | CHDI FOUNDATION, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-20150225451-A1 | HYDROXYSTATIN DERIVATIVES FOR THE TREATMENT OF ARTHROSIS | MERCK PATENT GMBH (DE) | 2015-08-13 | — | — | US | disclosed |
| EP-2885278-A1 | SUBSTITUTED PYRAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS | Janssen Pharmaceutica N.V. (BE) | 2015-06-24 | — | — | EP | disclosed |
| WO-2000069821-A1 | AROMATIC SULFONE HYDROXAMIC ACID METALLOPROTEASE INHIBITOR | G.D. SEARLE & CO. (US) | 2000-11-23 | — | — | WO | disclosed |
| WO-2000024251-A1 | COMPOSITION AND METHOD FOR COMBATTING PLANT FUNGI, AND PLANT FUNGUS INHIBITING COMPOUNDS | GREEN CARE LABORATORIES LTD. (IL) | 2000-05-04 | — | — | WO | disclosed |
| EP-0903349-A2 | CCR-3 receptor antagonists | F. HOFFMANN-LA ROCHE AG (CH) | 1999-03-24 | — | — | EP | disclosed |
| EP-0305242-B1 | 17-Aryl steroids, their preparation and intermediates for their preparation, their use as medicines and pharmaceutical compositions containing them | ROUSSEL UCLAF (FR) | 1994-01-05 | — | — | EP | disclosed |
| EP-0305242-A1 | 17-Aryl steroids, their preparation and intermediates for their preparation, their use as medicines and pharmaceutical compositions containing them | ROUSSEL-UCLAF (FR) | 1989-03-01 | — | — | EP | disclosed |
| US-4550111-A | BETA-ADRENERGIC BLOCKING AGENTS; DIURETICS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1985-10-29 | — | — | US | disclosed |
| EP-0096987-A2 | Hydroformylation process | DAVY McKEE (LONDON) LIMITED (GB) | 1983-12-28 | — | — | EP | disclosed |